← Back to Analyst Consensus 
ENSC Buy
Ensysce Biosciences, Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 20, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| Sep 25, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Jul 3, 2023 | HC Wainwright & Co. | initiate | — → Buy | $9 | 44% |
Price Target Trend
Apr 21, 2026 Oct 26, 2026
EPS Estimates
+1q —
0y —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days